Search
Ocular Therapeutix Inc
OCULAdd to Watchlist
6.210USD
-0.070-1.11%
Close 11-13 16:00（ET）
1.36BMarket Cap
LossP/E TTM
Ocular Therapeutix Inc (OCUL) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Ocular Therapeutix Inc in the past month.
Buy
4 Strong Buy
8 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
26.182USD+275.64%
OCUL Analyst Recommendation Trends
In the current month, OCUL has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OCUL average Analyst price target in the last month is 26.182.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
5
8
8
8
8
8
8
8
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
12
12
12
12
13
OCUL Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, OCUL EPS is projected to reach -0.416 in FY2026Q4, following reported EPS of -0.420 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.31
-0.40
-0.36
-0.42
-0.41
Actual
-0.40
-0.35
-0.42
--
--
Surprise
-26.63%
+11.46%
-15.89%
--
--
FAQs
What is Ocular Therapeutix Inc's expected revenue for the next quarter?
Ocular Therapeutix Inc's expected revenue is 13.75M.
What is Ocular Therapeutix Inc's price target?
Analysts forecast that Ocular Therapeutix Inc's price target is USD 26.18, with the highest forecast at USD 34.00 and the lowest forecast at USD 14.00.
How have Ocular Therapeutix IncOCUL's recent earnings per share performed?
The market expectation was USD -0.42, while Ocular Therapeutix IncOCUL's earnings per share (EPS) for the previous quarter was USD -0.35. EPS for the next quarter is expected at USD -0.42.
What is the analyst rating for Ocular Therapeutix Inc?
Based on the ratings of Ocular Therapeutix Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.